Patents by Inventor David J. Conn

David J. Conn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1 Receptor Agonists and Uses Thereof
    Publication number: 20240132483
    Abstract: Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, and 7-aza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
    Type: Application
    Filed: November 20, 2023
    Publication date: April 25, 2024
    Applicant: Pfizer Inc.
    Inventors: Gary Erik Aspnes, Scott W. Bagley, Edward L. Conn, John M. Curto, David J. Edmonds, Mark E. Flanagan, Kentaro Futatsugi, David A. Griffith, Kim Huard, Chris Limberakis, Alan M. Mathiowetz, David W. Piotrowski, Roger B. Ruggeri
  • Substituted-2,3-dihydro-6-substituted-pyrimido[2,1-F]-purine- 4,8(1H,9H)-diones
    Patent number: 4847377
    Abstract: Substituted 2,3-dihydro-6-substituted-pyrimido[2,1-f]purine-4,8(1H, 9H)-diones, their tautomers and salts, are disclosed for use as antihyperproliferative skin disease agents.Methods for their preparation and use are described.
    Type: Grant
    Filed: October 8, 1987
    Date of Patent: July 11, 1989
    Assignee: Schering Corporation
    Inventors: Daniel M. Solomon, James J. Kaminski, David J. Conn
  • Anti-inflammatory and anti-allergic substituted-2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]-purine-4,8(1H,9H)-dio nes
    Patent number: 4666914
    Abstract: Substituted 2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]purine-4,8(1H,9H)-diones their tautomers and salts, are anti-inflammatory and anti-allergy agents.Methods for their preparation and use are described.
    Type: Grant
    Filed: May 13, 1985
    Date of Patent: May 19, 1987
    Assignee: Schering Corporation
    Inventors: Daniel M. Solomon, James J. Kaminski, David J. Conn